Moderna Stock Craters 30 Percent In A Week
Interesting to see Moderna Inc (NASDAQ:MRNA) down more than 30 percent over the last 5 days, even as some other pharmaceutical/drug stocks are up or trading sideways.
Not financial advice, and FULCRUM has no skin in this game, but if equity markets are near perfect bastions of information analysis — what new information or perceived information might the market be digesting here?
One of the earliest mRNA vaccine mass manufacturers of the pandemic era has lost nearly one-third of its market cap in less than a week, and traditional media seem (almost) silent on the matter.